Table 3.
Morphological CMR parameters.
| Variable | Myocarditis (n = 15) | MINOCA (n = 14) | Takotsubo Cardiomyopathy (n = 9) | All Patients (n = 38) | p-Value * | p-Value † | p-Value ‡ |
|---|---|---|---|---|---|---|---|
| EDVi LV (mL/mq) | 87.00 ± 13.05 | 81.69 ± 20.16 | 77.75 ± 11.56 | 83.69 ± 16.09 | 0.410 | 0.216 | 0.718 |
| ESVi LV (mL/mq) | 36.53 ± 8.23 | 34.77 ± 12.59 | 37.00 ± 11.74 | 35.88 ± 10.30 | 0.660 | 0.927 | 0.758 |
| LV ejection fraction (%) | 58.13 ± 6.12 | 57.92 ± 6.87 | 53.50 ± 10.63 | 57.47 ± 6.96 | 0.933 | 0.264 | 0.335 |
| LV mass (g/mq) | 64.27 ± 15.40 | 60.92 ± 14.99 | 58.75 ± 8.96 | 62.22 ± 14.36 | 0.567 | 0.507 | 0.790 |
| LV regional wall motion | 4 (26.7%) | 4 (28.6%) | 9 (100%) | 17 (44.7%) | 0.910 | 0.0006 | 0.0010 |
| EDVi RV (mL/mq) | 88.13 ± 16.27 | 80.15 ± 20.05 | 69.50 ± 6.03 | 82.56 ± 17.83 | 0.255 | 0.003 | 0.320 |
| ESVi RV (mL/mq) | 38.13 ± 11.09 | 33.85 ± 10.76 | 28.50 ± 3.70 | 35.19 ± 10.61 | 0.310 | 0.111 | 0.354 |
| RV ejection fraction (%) | 57.33 ± 6.97 | 58.00 ± 6.03 | 58.75 ± 8.18 | 57.78 ± 6.53 | 0.790 | 0.731 | 0.843 |
| RV regional wall motion | 1 (6.7%) | 0 (0.0%) | 0 (0.0%) | 1 (2.6%) | 0.558 | 0.558 | 1.000 |
| Tissue Characterization | |||||||
| LV edema | 9 (60.0%) | 7 (50.0%) | 6 (66.7%) | 22 (57.9%) | 0.754 | 0.605 | 0.484 |
| LV LGE | 13 (86.7%) | 11 (78.57%) | 3 (33.3%) | 27 (71%) |
0.164 | 0.0085 | 0.0005 |
| LGE LV ischemic pattern | 0 (0.0%) | 11 (78.57%) | 0 (0.0%) | 11 (29%) |
<0.0001 | 0 | <0.0001 |
| RV edema | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 0 | 0 | 0 |
| RV LGE | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 0 | 0 | 0 |
* p-value between myocarditis and MINOCA; † p-value between myocarditis and takotsubo; ‡ p-value between takotsubo and MINOCA.